Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy
Wilson, L.; Sheehan, J.; Thorpe, M.
Irish Medical Journal 106(1): 24-25
2013
ISSN/ISBN: 0332-3102 PMID: 23472375 Document Number: 666986
Impulse control disorders (ICDs) are a known side effect of dopamine replacement therapy in patients with Parkinson's disease (PD). They can have devastating consequences for patients and their families.
Document emailed within 1 workday
Related Documents
Burkhard, P.R.; Catalano-Chiuvé, S.; Gronchi-Perrin, A.; Berney, A.; Vingerhoets, F.J.G.; Lüscher, C. 2008: Impulse control disorders and Parkinson's disease Revue Medicale Suisse 4(156): 1145-1148; 1150Nelis, E.A.; Berendse, H.W.; van den Heuvel, O.A. 2016: Hypersexuality and other impulse control disorders in Parkinson's disease Nederlands Tijdschrift Voor Geneeskunde 160: A9359
Routh, J.I.; Bannow, R.E.; Fincham, R.W.; Stoll, J.L. 1971: Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy Clinical Chemistry 17(9): 867-871
Bode, M. 2009: Dopamine agonist therapy in early Parkinson's disease. a survey of a Cochrane review Ugeskrift for Laeger 171(41): 2996-2999
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Boner, G.; Kristal, H. 1983: Neoplastic disease in patients receiving dialytic therapy and in patients after receiving transplantation Harefuah 104(2): 68-69
Buscaino, G.A.; Sori, A.; Campanella, G. 1972: Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa Revue Neurologique (Paris) 127(2): 301-302
Schrander-v d Meer, A.M.; van Saase, J.L.; Roodvoets, A.P.; van Dorp, W.T. 1995: Mortality in patients receiving renal replacement therapy, a single center study Clinical Nephrology 43(3): 174-179
Levin, O.S.; Nesterova, O.S.; Otcheskaia, O.V.; Zhuravleva, E.I.; Artemova, I.I.; Khozova, A.A.; Ismailov, A.M.; Lisenker, L.N.; Vdovichenko, T.V.; Rotor, L.D.; Ganzula, P.A.; Ivanov, A.K.; Boĭko, A.N. 2009: Influence of dopamine agonist pramipexole (mirapex) on tremor, cognitive and affective impairment in patients with Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(8): 36-41
Van Campenhout, J.; Choquette, P.; Vauclair, R. 1980: Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy Obstetrics and Gynecology 56(3): 349-355
Gekht, A.B. 2002: Use of dopamine agonists in the treatment of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(9): 54-58
Deam, D.R.; Campbell, D.G.; Ratnaike, S. 1983: Effect of oral intake of thyroxine on results of thyroid function tests in patients receiving thyroid replacement therapy Medical Journal of Australia 2(8): 374-376
Jenner, P. 2005: A novel dopamine agonist for the transdermal treatment of Parkinson's disease Neurology 65(2 Suppl 1): S3-S5
Stoessl, A.J.; de la Fuente-Fernández, R.úl. 2003: Dopamine receptors in Parkinson's disease: imaging studies Advances in Neurology 91: 65-71
Kish, S.; Rajput, A.; Gilbert, J.; Rozdilsky, B.; Chang, L.J.; Shannak, K.; Hornykiewicz, O. 1987: GABA-dopamine relationship in Parkinson's disease striatum Advances in Neurology 45: 75-77
Molho, E.S.; Factor, S.A.; Weiner, W.J.; Sanchez-Ramos, J.R.; Singer, C.; Shulman, L.; Brown, D.; Sheldon, C. 1995: The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease Journal of Neural Transmission. Supplementum 45: 225-230
Staeheli, J.W.; Frassica, F.J.; Sim, F.H. 1988: Prosthetic replacement of the femoral head for fracture of the femoral neck in patients who have Parkinson disease Journal of Bone and Joint Surgery. American Volume 70(4): 565-568
Thaut, M.H.; McIntosh, K.W.; McIntosh, G.C.; Hoemberg, V. 2001: Auditory rhythmicity enhances movement and speech motor control in patients with Parkinson's disease Functional Neurology 16(2): 163-172
Olanow, C.Warren. 2002: The role of dopamine agonists in the treatment of early Parkinson's disease Neurology 58(4 Suppl 1): S33-S41